Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quetiapine 25mg/5ml oral suspension
0402010ABAABDBD
|
Quetiapine | Quetiapine | Central Nervous System | 140 |
|
Atrolak XL 50mg tablets
0402010ABBGAAAV
|
Atrolak XL | Quetiapine | Central Nervous System | 117 |
|
Quetiapine 50mg/5ml oral suspension
0402010ABAABEBE
|
Quetiapine | Quetiapine | Central Nervous System | 103 |
|
Quetiapine 100mg/5ml oral liquid
0402010ABAAAMAM
|
Quetiapine | Quetiapine | Central Nervous System | 59 |
|
Atrolak XL 300mg tablets
0402010ABBGACAX
|
Atrolak XL | Quetiapine | Central Nervous System | 53 |
|
Quetiapine 12.5mg/5ml oral solution
0402010ABAAAIAI
|
Quetiapine | Quetiapine | Central Nervous System | 53 |
|
Atrolak XL 400mg tablets
0402010ABBGADAY
|
Atrolak XL | Quetiapine | Central Nervous System | 30 |
|
Quetiapine 200mg/5ml oral suspension
0402010ABAAARAR
|
Quetiapine | Quetiapine | Central Nervous System | 27 |
|
Atrolak XL 200mg tablets
0402010ABBGABAW
|
Atrolak XL | Quetiapine | Central Nervous System | 21 |
|
Quetiapine 25mg/5ml oral solution
0402010ABAAAHAH
|
Quetiapine | Quetiapine | Central Nervous System | 18 |
|
Quetiapine 50mg/5ml oral solution
0402010ABAAALAL
|
Quetiapine | Quetiapine | Central Nervous System | 16 |
|
Atrolak XL 150mg tablets
0402010ABBGAEBA
|
Atrolak XL | Quetiapine | Central Nervous System | 13 |
|
Ebesque XL 300mg tablets
0402010ABBFACAX
|
Ebesque XL | Quetiapine | Central Nervous System | 5 |
|
Ebesque XL 200mg tablets
0402010ABBFABAW
|
Ebesque XL | Quetiapine | Central Nervous System | 1 |
|
Ebesque XL 400mg tablets
0402010ABBFADAY
|
Ebesque XL | Quetiapine | Central Nervous System | No data available |
|
Ebesque XL 50mg tablets
0402010ABBFAAAV
|
Ebesque XL | Quetiapine | Central Nervous System | No data available |
|
Generic Seroquel tablets starter pack
0402010ABAAAGAG
|
Quetiapine | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 150mg tablets
0402010ABBKABBA
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 200mg tablets
0402010ABBKACAW
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 300mg tablets
0402010ABBKADAX
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 400mg tablets
0402010ABBKAEAY
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Psyquet XL 50mg tablets
0402010ABBKAAAV
|
Psyquet XL | Quetiapine | Central Nervous System | No data available |
|
Quetiapine 100mg oral powder sachets
0402010ABAAAPAP
|
Quetiapine | Quetiapine | Central Nervous System | No data available |
|
Quetiapine 125mg/5ml oral liquid
0402010ABAAAEAE
|
Quetiapine | Quetiapine | Central Nervous System | No data available |
|
Quetiapine 150mg/5ml oral liquid
0402010ABAAAJAJ
|
Quetiapine | Quetiapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.